BIOMAT Database Logo BIOMAT Database Logo

New 5-hydroxy-2-indolecarbohydrazides as platelet aggregation inhibitors in ethylene glycol. 1978

A Monge, and I Genua, and J A Palop, and M T Martinez, and F Roldan, and J Fernández

The effect of ethylene glycol on blood platelet aggregation was examined using a previously described method. This method also was used to investigate several derivatives of 2-indolecarbohydrazide in vitro. All compounds inhibited platelet aggregation induced by collagen, epinephrine, or adenosine diphosphate at concentrations below 5 x 10(-4) M.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D005026 Ethylene Glycols An ethylene compound with two hydroxy groups (-OH) located on adjacent carbons. They are viscous and colorless liquids. Some are used as anesthetics or hypnotics. However, the class is best known for their use as a coolant or antifreeze. Dihydroxyethanes,Ethanediols,Glycols, Ethylene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006834 Hydrazines Substituted derivatives of hydrazine (formula H2N-NH2). Hydrazide
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

A Monge, and I Genua, and J A Palop, and M T Martinez, and F Roldan, and J Fernández
New carbamoylpiperidines as human platelet aggregation inhibitors.
May 2000, Bioorganic & medicinal chemistry,
A Monge, and I Genua, and J A Palop, and M T Martinez, and F Roldan, and J Fernández
Platelet aggregation inhibitors. 2. Inhibition of platelet aggregation by 5'-, 2-, 6-, and 8-substituted adenosines.
April 1972, Journal of medicinal chemistry,
A Monge, and I Genua, and J A Palop, and M T Martinez, and F Roldan, and J Fernández
New platelet aggregation inhibitors.
December 1989, Chemical & pharmaceutical bulletin,
A Monge, and I Genua, and J A Palop, and M T Martinez, and F Roldan, and J Fernández
New pyrazolylhydrazone derivatives as inhibitors of platelet aggregation.
July 1993, The Journal of pharmacy and pharmacology,
A Monge, and I Genua, and J A Palop, and M T Martinez, and F Roldan, and J Fernández
Platelet aggregation inhibitors. 7. S-substituted 2-thioadenosine 5'-monophosphates.
December 1973, Journal of medicinal chemistry,
A Monge, and I Genua, and J A Palop, and M T Martinez, and F Roldan, and J Fernández
New inhibitors of platelet aggregation. 5'-Phosphate, 5'-phosphorothioate, and 5'-O-sulfamoyl derivatives of 2-substituted adenosine analogues.
June 1978, Journal of medicinal chemistry,
A Monge, and I Genua, and J A Palop, and M T Martinez, and F Roldan, and J Fernández
2-Pyridylarylhydrazone derivatives, a new class of platelet aggregation inhibitors.
March 1996, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
A Monge, and I Genua, and J A Palop, and M T Martinez, and F Roldan, and J Fernández
Platelet aggregation inhibitors. VIII. 2-Thioadenine derivatives.
July 1977, Chemical & pharmaceutical bulletin,
A Monge, and I Genua, and J A Palop, and M T Martinez, and F Roldan, and J Fernández
Platelet aggregation inhibitors. 6. 2-Thioadenosine derivatives.
December 1973, Journal of medicinal chemistry,
A Monge, and I Genua, and J A Palop, and M T Martinez, and F Roldan, and J Fernández
Bicyclic thiophenic derivatives as platelet aggregation inhibitors.
June 1986, Il Farmaco; edizione scientifica,
Copied contents to your clipboard!